---
document_datetime: 2026-01-26 11:53:23
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zegalogue-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: zegalogue-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.2971494
conversion_datetime: 2026-01-29 12:10:47.832967
docling_version:
  docling-serve: 1.11.0
  docling-jobkit: 1.9.0
  docling: 2.70.0
  docling-core: 2.61.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zegalogue

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number      | Scope                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|-------------------------|-------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Marketing Authorisation | - Transfer of a marketing authorisation - | 19/12/2025                          | 19/01/2026                                  | SmPC,                            |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| Transfer - H / EMA/T/0000316252          | Transfer of Marketing Authorisation from Novo Nordisk A/S to Zealand Pharma A/S                                                                                                                                                                                                                                              |            |            | Labelling and PL                 |
|------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| Variation type IA_IN / EMA/VR/0000263475 | This was an application for a group of variations. B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.1 Not including batch control/testing - Accepted B.II.e.5 Change in pack size of the finished product - B.II.e.5.b Deletion of pack size(s) - Accepted | 22/04/2025 | 19/01/2026 | SmPC, Annex II, Labelling and PL |
| PSUR / EMA/PSUR/0000269023               | - -                                                                                                                                                                                                                                                                                                                          |            |            |                                  |